HUM
NYSE · Health Care
Humana Inc
$375.73
+3.73 (+1.00%)
HUM News30 articles
Humana's Medicare Exit: 600,000 Members to Go, Margin Recovery in Focus
Humana will discontinue Medicare Advantage plans for about 600,000 members in 2027, expecting to recapture 40%. The move aims to restore margins, but shares fell 1.8%.
Humana Gains as COLA Estimate Overlooks Rising Medical Costs
Humana stock gained 2.6% as a preliminary 3.1% COLA estimate for 2027 overshadowed rising medical costs, which continue to pressure the insurer's margins.
UnitedHealth's Optum Health Beats 2026 Profit Goal, Investors Eye 2027 Growth
Optum Health reported $2.486B in adjusted operating earnings for H1 2026, beating its full-year minimum target by 12%, but investors look to 2027 for sustained growth.
Dow Rises on Rate-Sensitive Gains While Market Breadth Weakens
The Dow gained 0.87% even as private payrolls missed forecasts and ISM prices jumped. Nasdaq and small caps declined, with weak breadth and healthcare outperforming tech.
Medicare Part D Subsidy Phaseout Poses Enrollment Risks for Standalone Plans
Centene (CNC) is most exposed to Medicare Part D subsidy phaseout, with 90% of its drug plan members in standalone plans. The end of the $3.6B demo could trigger enrollment shifts.
Humana's Medicare Advantage Restructuring Overshadows Strong Q2 Results
Humana's Q2 earnings beat was overshadowed by a major Medicare Advantage restructuring that will affect 600,000 members by 2027, sending shares down 6.8%.
Medicare Part D Subsidy Phaseout Widens Insurer Pricing Gap
CMS plans to end temporary Part D assistance after 2026, with 2027 bids up 23.7%. Insurers like Centene face enrollment risk as pricing gaps widen.
Humana Stock Tumbles 8% Premarket Despite Strong Q2, 2026 Outlook Signals Sharp H2 Loss
Humana shares dropped 8% premarket despite Q2 earnings and revenue beats, as the 2026 adjusted EPS floor of $9 implies a second-half loss of $8.91 per share.
Abbott Leads Healthcare Surge as Insurers Show Mixed Results
Abbott Laboratories surged 10.9% despite a modest earnings beat, while UnitedHealth rose 2.6% on a larger beat. The healthcare sector ETF XLV gained 2.2%.
Humana Stock Slides 3.6% as High Valuation Meets Earnings Reality Check
Humana shares dropped 3.6% on Thursday, giving back an initial 4.1% rise, as investors reassess the stock's premium valuation ahead of its July 29 earnings report.
Healthcare Earnings Test: J&J, UnitedHealth, Abbott in Focus After Sector's 9% Drop
Major healthcare stocks report this week as the sector's 9% earnings decline goes under the microscope. J&J, UnitedHealth, and Abbott are key to determining if the drop is real or just a one-off.
Alignment Healthcare Stock Plunges 16.7% on Whistleblower Suit Alleging Expense Misreporting
Alignment Healthcare shares dropped 16.7% on July 8, 2026, following a whistleblower lawsuit from a former executive alleging expense misreporting. The company denies the claims and vows to defend itself.
AI-Driven Healthcare Fraud Surge Strains Insurers, Coverage Gaps Widen
AI is fueling healthcare fraud with fake medical records and bot calls, driving up costs and exposing coverage gaps as insurers scramble to adapt.
Alignment Healthcare Surges 25% on Raised 2026 Guidance, Strong Q1
Alignment Healthcare stock surged 25% after raising its 2026 guidance and reporting strong Q1 earnings, driven by disciplined growth and stable utilization trends.
UnitedHealth Rises as Analysts See Easing Medical Costs
UnitedHealth shares climbed 5.7% after Bank of America upgraded the stock to Buy and Morgan Stanley raised its price target, citing easing medical costs and a favorable Q2 setup.
UnitedHealth Drops Premarket After Berkshire Exits Stake
UnitedHealth shares dropped 4.8% in premarket trading after Berkshire Hathaway disclosed it sold its stake in the insurer, dampening sentiment despite strong Q1 results.
Stocks Dip as Oil Surge Fuels Inflation Fears, Fed Cut Hopes Fade
US stocks retreated Tuesday as a hotter-than-expected April CPI report and surging oil prices dampened rate-cut expectations, with tech and chip stocks leading declines.
UnitedHealth Shares Surge as Investors Bet on Recovery, PBM Reform
UnitedHealth shares climbed 3.1% as the company unveiled a new Optum Rx fee-based pricing model and raised 2026 profit guidance, signaling a potential turnaround.
Humana Shares Surge 11% on Medicare Advantage Optimism
Humana shares surged 11.27% on Friday amid renewed Medicare Advantage optimism after CVS raised its 2026 profit outlook, though concerns over Star Ratings and funding persist.
UnitedHealth Stock Rebounds on Easing Medical Costs and Raised Outlook
UnitedHealth shares rose 2.8% to $379.98, extending gains on easing medical-cost pressures. Q1 revenue hit $111.7B, and the company raised its full-year adjusted earnings outlook above $18.25/share.
Humana Stock Rally Tests Valuation as Profit Forecast Slips
Humana lowered its 2026 GAAP EPS forecast to at least $8.36, while its stock has surged over 25% in a month, pushing the P/E ratio above 26.
Blue Cross Blue Shield $2.67B Settlement Payouts Begin in May 2026
Blue Cross Blue Shield settlement payments start in May 2026 for eligible claimants in a $2.67 billion antitrust case. Payouts vary based on claims and premiums, with an estimated average of $333.
UnitedHealth Eases Prior Authorization Rules; UNH Shares Gain
UnitedHealth Group shares climbed 1% after the company announced it will eliminate prior authorization for 30% of services by 2026, including outpatient surgeries and diagnostic tests.
Humana Shares Slide Despite Q1 Earnings Beat as Medicare Advantage Challenges Persist
Humana beat Q1 profit estimates but shares fell over 6% premarket as it kept its 2026 outlook unchanged and cut GAAP guidance, citing Medicare Star Ratings headwinds.
Blue Cross Blue Shield Settlement Payouts to Begin in May
Payments from the $2.67 billion Blue Cross Blue Shield antitrust settlement begin in May 2026 for eligible claimants who filed by November 2021.
UnitedHealth, Health Insurers Rally on Centene Profit Outlook Boost
UnitedHealth Group shares rose about 4% Tuesday after Centene lifted its profit outlook, fueling hopes that medical-cost pressures are easing for major insurers.
Futures Gain on Iran Ceasefire Extension; Tesla, Airlines in Focus
U.S. stock futures advanced Wednesday morning following an extension of the Iran ceasefire. Investors are monitoring oil prices and a busy earnings calendar featuring Tesla and United Airlines.
Stocks Retreat as Oil Surge, Fed Jitters Undercut Rally
Major U.S. equity indices turned lower Tuesday afternoon, surrendering morning advances as climbing crude prices and bond yields introduced fresh uncertainty. The S&P 500 declined 0.32% to 7,086.48.
UnitedHealth Shares Rally on Medicare Advantage Rate Decision Ahead of Q1 Report
UnitedHealth Group shares advanced following a finalized 2.48% increase to 2027 Medicare Advantage payment rates, which exceeds initial projections. The company is set to report first-quarter results on April 21 amid expectations for an earnings decline.
UnitedHealth Shares Drop Ahead of Q1 Report, Sector Under Pressure
UnitedHealth Group shares declined sharply Friday, extending weekly losses as the market anticipates first-quarter results. The health insurance sector broadly retreated.